Epistem Holdings Plc: Successful Clinical Trial validates use of Genedrive(R) in Human Genotyping Application
May 03, 2016 02:00 ET
|
Epistem plc
MANCHESTER, UNITED KINGDOM--(Marketwired - May 3, 2016) - Epistem Holdings Plc (LSE:EHP), the molecular diagnostics, personalised medicine and biotechnology company, today announces the...
Epistem Announces Successful External Assessment of Genedrive(R) Hepatitis C Test at the Institut Pasteur and Commencement of Clinical Studies
February 18, 2016 07:09 ET
|
Epistem plc
MANCHESTER, UNITED KINGDOM--(Marketwired - Feb. 18, 2016) - Epistem Holdings Plc (LSE:EHP), the personalised medicine and biotechnology company, announces today that its Genedrive®...
U.S. Department of Defense to Fund Research at Indiana University and Epistem UK Investigating Treatments for Radiation Sickness
November 11, 2015 02:00 ET
|
Epistem plc
MANCHESTER, UNITED KINGDOM--(Marketwired - Nov. 11, 2015) - Epistem Holdings Plc (LSE:EHP) ("Epistem" or "the Company"), the personalised medicine and biotechnology company, which has...
CORRECTION FROM SOURCE: Indian Approval of Import Licence for Genedrive(R) TB Molecular Diagnostic Test
April 23, 2015 07:42 ET
|
Epistem plc
MANCHESTER, UNITED KINGDOM--(Marketwired - April 23, 2015) -
This document corrects and replaces the press release that was sent today at 4:47:07 AM EDT
Epistem Holdings...
Indian Approval of Import Licence for Genedrive(R) TB Molecular Diagnostic Test
April 23, 2015 04:47 ET
|
Epistem plc
MANCHESTER, UNITED KINGDOM--(Marketwired - April 23, 2015) - Epistem Holdings Plc (LSE:EHP), the personalised medicine and biotechnology company, announces today that the Drug Controller...
Epistem and CRT Announce Agreement for the Use of Patient Derived Leukemic Samples
April 21, 2015 02:00 ET
|
Epistem plc
MANCHESTER, UNITED KINGDOM--(Marketwired - April 21, 2015) - Epistem Holdings Plc (LSE:EHP)(AIM:EHP.L), Manchester, UK, the biotechnology and personalized medicine company, is pleased to...